Correlation Between Johnson Johnson and Crinetics Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Johnson Johnson and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Crinetics Pharmaceuticals.

Diversification Opportunities for Johnson Johnson and Crinetics Pharmaceuticals

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Johnson and Crinetics is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Crinetics Pharmaceuticals go up and down completely randomly.

Pair Corralation between Johnson Johnson and Crinetics Pharmaceuticals

Considering the 90-day investment horizon Johnson Johnson is expected to generate 6.27 times less return on investment than Crinetics Pharmaceuticals. But when comparing it to its historical volatility, Johnson Johnson is 4.22 times less risky than Crinetics Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,779  in Crinetics Pharmaceuticals on December 1, 2024 and sell it today you would earn a total of  1,542  from holding Crinetics Pharmaceuticals or generate 86.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  Crinetics Pharmaceuticals

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Johnson Johnson are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Johnson Johnson may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Crinetics Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Crinetics Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Johnson Johnson and Crinetics Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Crinetics Pharmaceuticals

The main advantage of trading using opposite Johnson Johnson and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.
The idea behind Johnson Johnson and Crinetics Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities